U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
camrelizumab [INN]
Preferred Name English
CAMRELIZUMAB
INN   WHO-DD  
INN  
Official Name English
Carilizumab
Common Name English
Carrelizumab
Common Name English
Camrelizumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G4, ANTI-(CELL SURFACE RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL SHR-1210 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SHR-1210 LIGHT CHAIN, DIMER
Systematic Name English
ANTI-PD-1 MONOCLONAL ANTIBODY SHR-1210
Common Name English
SHR-1210
Code English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
NCI_THESAURUS C128037
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
FDA ORPHAN DRUG 675718
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
Code System Code Type Description
SMS_ID
100000174636
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
FDA UNII
73096E137E
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
INN
10400
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
CAS
1798286-48-2
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
DRUG BANK
DB14776
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
WIKIPEDIA
Camrelizumab
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
NCI_THESAURUS
C123816
Created by admin on Wed Apr 02 09:32:45 GMT 2025 , Edited by admin on Wed Apr 02 09:32:45 GMT 2025
PRIMARY
ACTIVE MOIETY
CAMRELIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966